Fertility Drugs and Cancer
Bay IVF - Advanced Reproductive Care                                Palo Alto  650-322-0500

 

Fertility Drugs and Cancer

Adapted from “Fertility drugs and cancer: a guideline” by American Society for Reproductive Medicine (ASRM).

Infertile women may be at an increased risk of developing invasive ovarian, endometrial, and breast cancer. Ever wonder whether taking fertility drugs further increases this risk?

The following are scientific evidence-based summary statements issued by ASRM in December 2016:

Ovarian Cancer
Available data is reasonably reassuring that there is no meaningful increased risk of invasive ovarian cancer following the use of fertility drugs in infertile women.

Breast Cancer
There is fair evidence that fertility drugs are not associated with an increased risk of breast cancer.

Endometrial Cancer
There is fair evidence that fertility drugs are not associated with an increased risk of endometrial cancer.

Thyroid Cancer
There is fair evidence that fertility drugs are not associated with an increased risk of invasive thyroid cancer.

Melanoma
There is insufficient evidence that fertility drugs are associated with an increased risk of melanoma.

Colon Cancer
There is fair evidence that fertility drugs are not associated with an increased risk of colon cancer.

Cervical Cancer
There is fair evidence that fertility drugs are not associated with an increased risk of cervical cancer.

Recommendation
Given the available literature, patients should be counseled that even though infertile women may be at an increased risk of invasive ovarian, endometrial, and breast cancer, the use of fertility drugs does not appear to increase this risk.

March 2018

Request Information
or a Consultation
with Dr. Polansky

 

Thank you.
We will contact you as soon as possible.